These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2137563)

  • 1. Highly potent inhibitory effects of 5-HT3 receptor antagonist, GR38032F, on non-opioid defeat analgesia in male mice.
    Rodgers RJ; Shepherd JK; Randall JI
    Neuropharmacology; 1990 Jan; 29(1):17-23. PubMed ID: 2137563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist.
    Jones BJ; Costall B; Domeney AM; Kelly ME; Naylor RJ; Oakley NR; Tyers MB
    Br J Pharmacol; 1988 Apr; 93(4):985-93. PubMed ID: 2898961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors.
    Butler A; Hill JM; Ireland SJ; Jordan CC; Tyers MB
    Br J Pharmacol; 1988 Jun; 94(2):397-412. PubMed ID: 2969267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of the analgesic consequences of social defeat in male mice by 5-HT1A anxiolytics, buspirone, gepirone and ipsapirone.
    Rodgers RJ; Shepherd JK
    Psychopharmacology (Berl); 1989; 99(3):374-80. PubMed ID: 2574479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
    Cohen ML; Bloomquist W; Gidda JS; Lacefield W
    J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent inhibition of non-opioid defeat analgesia in male mice by benzodiazepine antagonist Ro15-3505.
    Rodgers RJ; Randall JI
    Physiol Behav; 1988; 42(5):461-4. PubMed ID: 3393607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5HT1A agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), inhibits non-opioid analgesia in defeated mice: influence of route of administration.
    Rodgers RJ; Shepherd JK
    Psychopharmacology (Berl); 1989; 97(2):163-5. PubMed ID: 2524855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of defensive analgesia in male mice by 5-HT3 receptor antagonists, ICS 205-930, MDL 72222, MDL 73147EF and MDL 72699.
    Rodgers RJ; Shepherd JK
    Neuropharmacology; 1992 Jun; 31(6):553-60. PubMed ID: 1407395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereospecific inhibition of non-opioid defeat analgesia in male mice by MDL 72832, a selective 5-HT1A receptor agonist.
    Rodgers RJ; Shepherd JK
    Eur J Pharmacol; 1990 Jul; 182(3):581-5. PubMed ID: 2226625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of novel ligands for 5-HT receptor subtypes on nonopioid defensive analgesia in male mice.
    Rodgers RJ; Shepherd JK; Donát P
    Neurosci Biobehav Rev; 1991; 15(4):489-95. PubMed ID: 1792010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic administration of ondansetron (GR38032F), a selective 5-HT3 receptor antagonist, on monoamine metabolism in mesolimbic and nigrostriatal dopaminergic neurons and on striatal D2-receptor binding.
    Koulu M; Lappalainen J; Hietala J; Sjöholm B
    Psychopharmacology (Berl); 1990; 101(2):168-71. PubMed ID: 2140903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute GR38032F (odansetron), a 5-HT3 receptor antagonist, on dopamine and serotonin metabolism in mesolimbic and nigrostriatal dopaminergic neurons.
    Koulu M; Sjöholm B; Lappalainen J; Virtanen R
    Eur J Pharmacol; 1989 Oct; 169(2-3):321-4. PubMed ID: 2530097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of the CCK antagonist, MK-329, on analgesia induced by morphine, social conflict (opioid) and defeat experience (non-opioid) in male mice.
    Hendrie CA; Shepherd JK; Rodgers RJ
    Neuropharmacology; 1989 Oct; 28(10):1025-32. PubMed ID: 2812281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzodiazepine ligands, nociception and 'defeat' analgesia in male mice.
    Rodgers RJ; Randall JI
    Psychopharmacology (Berl); 1987; 91(3):305-15. PubMed ID: 3104952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of non-opioid analgesia in intruder mice by selective neuronal and non-neuronal benzodiazepine recognition site ligands.
    Rodgers RJ; Randall JI
    Psychopharmacology (Berl); 1988; 96(1):45-54. PubMed ID: 2852378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
    Paul D; Yao D; Zhu P; Minor LD; Garcia MM
    J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential analgesic actions of serotonin 5-HT3 receptor antagonists in the mouse.
    Giordano J; Dyche J
    Neuropharmacology; 1989 Apr; 28(4):423-7. PubMed ID: 2526302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in rats.
    Goudie AJ; Leathley MJ
    Eur J Pharmacol; 1990 Aug; 185(2-3):179-86. PubMed ID: 1979273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of GR38032F, novel 5-HT3-receptor antagonist on gastric emptying in the guinea-pig.
    Costall B; Gunning SJ; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Jun; 91(2):263-4. PubMed ID: 2955843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.